Table 13 Early systemic complications and mortality in Inspiris Resilia versus other bioprosthesis in comparative studies (n = 5)
| Â | N | Complications | Mortality | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Arrhythmia | Pacemaker | Thromboembolic | Bleeding | Hemolysis | All-cause | Valve-related | |||||
All | Stroke | TIA | MI | ||||||||
Bernard 2023 [32] | |||||||||||
Inspiris Resilia | 217 | 76 | NA | 6 | 4 | 2 | 9 | NA | 6 | NA | |
Magna Ease | 217 | 87 | NA | 7 | 5 | 2 | 15 | NA | 5 | NA | |
Chiariello 2023 [35] | |||||||||||
Inspiris Resilia | 74 | NA | 2 | - | - | - | - | 6 | NA | 1 | - |
Avalus | 74 | NA | 4 | - | - | - | - | 2 | NA | 2 | 1 |
Francica 2023 [40] | |||||||||||
Inspiris Resilia | 122 | 31 # | 2 | 3 | NA | NA | NA | 2 | NA | - | - |
Magna Ease | 122 | 28 | 4 | 2 | NA | NA | NA | 5 | NA | - | - |
Maeda 2023 [34] | |||||||||||
Inspiris Resilia | 64 | NA | - | NA | NA | NA | NA | NA | NA | 1 | NA |
Magna Ease | 64 | NA | 4 | NA | NA | NA | NA | NA | NA | - | - |
Shala 2022 [33] | |||||||||||
Inspiris Resilia | 59 | - | - | 1 | 1 | - | - | 1 | NA | - | - |
Magna Ease | 66 | - | - | 1 | 1 | - | - | 1 | NA | 1 | 1 |